# First Horizon Corp: financial statements, quarterly

FHN · NYSE · CIK 36966 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fhn.md) · [Financials](/companies/fhn/financials.md) · [Filings](/companies/fhn/filings.md) · [Insiders](/companies/fhn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fhn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [819](/filings/0000036966-25-000053.md) | [9.0](/filings/0000036966-24-000084.md) | [827](/filings/0000036966-25-000155.md) | [728 d](/filings/0000036966-26-000051.md) | [812](/filings/0000036966-26-000112.md) | [830](/filings/0000036966-26-000155.md) | [889](/filings/0000036966-25-000155.md) | [888 d](/filings/0000036966-26-000051.md) | [862](/filings/0000036966-26-000112.md) | [887](/filings/0000036966-26-000155.md) |
| Interest expense | $m | [475](/filings/0000036966-23-000120.md) | [469 d](/filings/0000036966-24-000015.md) | [448](/filings/0000036966-24-000060.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [52.0](/filings/0000036966-24-000094.md) | [(11.0) d](/filings/0000036966-26-000051.md) | [57.0](/filings/0000036966-25-000053.md) | [56.0](/filings/0000036966-25-000110.md) | [58.0](/filings/0000036966-25-000155.md) | [40.0 d](/filings/0000036966-26-000051.md) | [63.0](/filings/0000036966-26-000112.md) | [64.0](/filings/0000036966-26-000155.md) | [78.0](/filings/0000036966-25-000155.md) | [77.0 d](/filings/0000036966-26-000051.md) | [76.0](/filings/0000036966-26-000112.md) | [66.0](/filings/0000036966-26-000155.md) |
| Net income | $m | [137](/filings/0000036966-24-000094.md) | [184 d](/filings/0000036966-26-000051.md) | [192](/filings/0000036966-25-000053.md) | [199](/filings/0000036966-25-000110.md) | [218](/filings/0000036966-25-000155.md) | [166 d](/filings/0000036966-26-000051.md) | [218](/filings/0000036966-26-000112.md) | [241](/filings/0000036966-26-000155.md) | [262](/filings/0000036966-25-000155.md) | [262 d](/filings/0000036966-26-000051.md) | [262](/filings/0000036966-26-000112.md) | [270](/filings/0000036966-26-000155.md) |
| Diluted EPS | $ per share | [0.23](/filings/0000036966-24-000094.md) | not reported | [0.33](/filings/0000036966-25-000053.md) | [0.34](/filings/0000036966-25-000110.md) | [0.40](/filings/0000036966-25-000155.md) | not reported | [0.41](/filings/0000036966-26-000112.md) | [0.45](/filings/0000036966-26-000155.md) | [0.50](/filings/0000036966-25-000155.md) | not reported | [0.53](/filings/0000036966-26-000112.md) | [0.54](/filings/0000036966-26-000155.md) |
| Basic EPS | $ per share | [0.23](/filings/0000036966-24-000094.md) | not reported | [0.33](/filings/0000036966-25-000053.md) | [0.34](/filings/0000036966-25-000110.md) | [0.40](/filings/0000036966-25-000155.md) | not reported | [0.41](/filings/0000036966-26-000112.md) | [0.46](/filings/0000036966-26-000155.md) | [0.50](/filings/0000036966-25-000155.md) | not reported | [0.54](/filings/0000036966-26-000112.md) | [0.55](/filings/0000036966-26-000155.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [82.5](/filings/0000036966-23-000120.md) | [81.7](/filings/0000036966-25-000024.md) | [81.8](/filings/0000036966-24-000060.md) | [82.2](/filings/0000036966-24-000084.md) | [82.6](/filings/0000036966-24-000094.md) | [82.2](/filings/0000036966-26-000051.md) | [81.5](/filings/0000036966-25-000053.md) | [82.1](/filings/0000036966-25-000110.md) | [83.2](/filings/0000036966-25-000155.md) | [83.9](/filings/0000036966-26-000155.md) | [84.1](/filings/0000036966-26-000112.md) | [84.4](/filings/0000036966-26-000155.md) |
| Total liabilities | $bn | [73.7](/filings/0000036966-23-000120.md) | [72.4](/filings/0000036966-25-000024.md) | [72.6](/filings/0000036966-24-000060.md) | [73.3](/filings/0000036966-24-000084.md) | [73.3](/filings/0000036966-24-000094.md) | [73.0](/filings/0000036966-26-000051.md) | [72.4](/filings/0000036966-25-000053.md) | [72.8](/filings/0000036966-25-000110.md) | [73.9](/filings/0000036966-25-000155.md) | [74.7](/filings/0000036966-26-000155.md) | [74.7](/filings/0000036966-26-000112.md) | [75.0](/filings/0000036966-26-000155.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [2.5](/filings/0000036966-23-000120.md) | [2.5](/filings/0000036966-25-000024.md) | [2.7](/filings/0000036966-24-000060.md) | [4.5](/filings/0000036966-24-000084.md) | [2.6](/filings/0000036966-24-000094.md) | [3.4](/filings/0000036966-26-000051.md) | [3.8](/filings/0000036966-25-000053.md) | [3.5](/filings/0000036966-25-000110.md) | [4.3](/filings/0000036966-25-000155.md) | [3.3](/filings/0000036966-26-000155.md) | [4.2](/filings/0000036966-26-000112.md) | [3.0](/filings/0000036966-26-000155.md) |
| Shareholders' equity | $bn | [8.5](/filings/0000036966-23-000120.md) | [9.0](/filings/0000036966-25-000024.md) | [8.9](/filings/0000036966-24-000060.md) | [8.7](/filings/0000036966-24-000084.md) | [9.0](/filings/0000036966-24-000094.md) | [8.8](/filings/0000036966-26-000051.md) | [8.7](/filings/0000036966-25-000053.md) | [9.0](/filings/0000036966-25-000110.md) | [8.9](/filings/0000036966-25-000155.md) | [8.8](/filings/0000036966-26-000155.md) | [9.2](/filings/0000036966-26-000112.md) | [9.2](/filings/0000036966-26-000155.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [698 d](/filings/0000036966-24-000094.md) | [365 d](/filings/0000036966-26-000051.md) | [838](/filings/0000036966-25-000053.md) | [(150) d](/filings/0000036966-25-000110.md) | [389 d](/filings/0000036966-25-000155.md) | [191 d](/filings/0000036966-26-000051.md) | [349](/filings/0000036966-26-000112.md) | [83.0 d](/filings/0000036966-26-000155.md) | [(200) d](/filings/0000036966-25-000155.md) | [396 d](/filings/0000036966-26-000051.md) | [278](/filings/0000036966-26-000112.md) | [585 d](/filings/0000036966-26-000155.md) |
| Capital expenditure | $m | not reported | [14.0 d](/filings/0000036966-26-000051.md) | [10.0](/filings/0000036966-25-000053.md) | [11.0 d](/filings/0000036966-25-000110.md) | [6.0 d](/filings/0000036966-25-000155.md) | [17.0 d](/filings/0000036966-26-000051.md) | [9.0](/filings/0000036966-26-000112.md) | [9.0 d](/filings/0000036966-26-000155.md) | [8.0 d](/filings/0000036966-25-000155.md) | [7.0 d](/filings/0000036966-26-000051.md) | [8.0](/filings/0000036966-26-000112.md) | [19.0 d](/filings/0000036966-26-000155.md) |
| Dividends paid | $m | [84.0 d](/filings/0000036966-24-000094.md) | [84.0 d](/filings/0000036966-26-000051.md) | [85.0](/filings/0000036966-25-000053.md) | [86.0 d](/filings/0000036966-25-000110.md) | [81.0 d](/filings/0000036966-25-000155.md) | [80.0 d](/filings/0000036966-26-000051.md) | [80.0](/filings/0000036966-26-000112.md) | [82.0 d](/filings/0000036966-26-000155.md) | [76.0 d](/filings/0000036966-25-000155.md) | [76.0 d](/filings/0000036966-26-000051.md) | [73.0](/filings/0000036966-26-000112.md) | [87.0 d](/filings/0000036966-26-000155.md) |
| Share repurchases | $m | [0.0 d](/filings/0000036966-24-000094.md) | [0.0 d](/filings/0000036966-26-000051.md) | [159](/filings/0000036966-25-000053.md) | [228 d](/filings/0000036966-25-000110.md) | [75.0 d](/filings/0000036966-25-000155.md) | [164 d](/filings/0000036966-26-000051.md) | [365](/filings/0000036966-26-000112.md) | [28.0 d](/filings/0000036966-26-000155.md) | [190 d](/filings/0000036966-25-000155.md) | [335 d](/filings/0000036966-26-000051.md) | [235](/filings/0000036966-26-000112.md) | [121 d](/filings/0000036966-26-000155.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [570](/filings/0000036966-23-000120.md) | [572](/filings/0000036966-24-000060.md) | [561](/filings/0000036966-24-000084.md) | [561](/filings/0000036966-24-000094.md) | [558](/filings/0000036966-25-000053.md) | [547](/filings/0000036966-25-000110.md) | [538](/filings/0000036966-25-000155.md) | [523](/filings/0000036966-26-000112.md) | [514](/filings/0000036966-26-000155.md) | [510](/filings/0000036966-25-000155.md) | [487](/filings/0000036966-26-000112.md) | [480](/filings/0000036966-26-000155.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 473,777,158 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000036966-26-000155.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.